3’-Dechloro-3’-bromo Bupropion Fumarate(CAS: 1251850-99-3)

3’-Dechloro-3’-bromo Bupropion Fumarate (CAS: 1251850-99-3) should comply with the Globally Harmonized System (GHS) for Classification and Labelling of Chemicals. Additionally, it is subject to REACH regulations within the EU, which require registration, evaluation, and authorization of chemicals. In the USA, FDA and EPA have specific requirements for the safe handling, storage, and disposal of this compound.

There are several alternatives to 3’-Dechloro-3’-bromo Bupropion Fumarate in synthesis, such as isomers and analogs with different halogen substitutions. Common alternatives include 3-Bromo-3-dechlorobupropion and 3-Chloro-3-bromobupropion. These can be used as substitutes in various chemical reactions depending on the desired properties.

The market and research trends for 3’-Dechloro-3’-bromo Bupropion Fumarate (CAS: 1251850-99-3) are focused on its use in pharmaceutical and analytical applications. Research is exploring its role in drug development and as a tool for studying bupropion analogs. Market trends indicate increasing interest in novel derivatives and their potential therapeutic uses.

Waste containing 3’-Dechloro-3’-bromo Bupropion Fumarate (CAS: 1251850-99-3) should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration is a common method, but precautions must be taken to ensure environmental safety. Environmental protection measures include proper labeling and documentation to comply with relevant regulations such as GHS and REACH standards.